Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors

OncoImmunology

Volumn 4, Issue 9, 2015, Pages 1-3

  Mitri, Diletta Di ^a   Toso, Alberto ^a   Alimonti, Andrea ^a  

^a INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; DOCETAXEL; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER INFILTRATION; CARCINOGENESIS; DNA DAMAGE; DRUG RESISTANCE; GENE MUTATION; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; SENESCENCE; TUMOR ESCAPE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84944457903     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/2162402X.2014.988473     Document Type: Article

References (10)

1. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10:51-7; PMID:20029423; http://dx.doi.org/10.1038/ nrc2772
2. Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307-15; PMID:15549092; http://dx.doi.org/10.1038/nature03098
3. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602; PMID:9054499; http://dx.doi. org/10.1016/S0092-8674(00)81902-9
4. Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst 2010; 102:1536-46; PMID:20858887; http://dx.doi. org/10.1093/jnci/djq364
5. BraumullerH, Wieder T, Brenner E, Assmann S,Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494:361-5; PMID:23376950; http://dx.doi.org/10.1038/nature11824
6. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436:725-30; PMID:16079851; http://dx.doi. org/10.1038/nature03918
7. Saab R. Senescence and pre-malignancy: how do tumors progress? Semin Cancer Biol 2011; 21:385-91; PMID:21982725; http://dx.doi.org/10.1016/j. semcancer.2011.09.013
8. Alimonti A, Nardella C, Chen Z, Clohessy JG, Carracedo A, Trotman LC, Cheng K, Varmeh S, Kozma SC, Thomas G, et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Cli Invest 2010; 120:681-93; PMID:20197621; http:// dx.doi.org/10.1172/JCI40535
9. Di Mitri D, Toso A, Chen JJ, Sarti M, Pinton S, Jost TR, D'Antuono R, Montani E, Garcia-Escudero R, Guccini I, et al. Tumour-infiltrating Gr-1C myeloid cells antagonize senescence in cancer. Nature 2014; 515:134-7; PMID:25156255; http://dx.doi.org/ 10.1038/nature13638
10. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013; 15:978-90; PMID:23770676; http://dx.doi.org/10.1038/ncb2784